Добро пожаловать
Зарегистрировать аккаунт
Войдите, используя email
Зарегистрируйтесь с помощью email
Проверь свои входящие
evonetix
About
Evonetix is a provider of a desktop platform designed to synthesize DNA at unprecedented accuracy and scale.
- 11 - 50
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $12.30M
- Industries
- Biopharma,Biotechnology,Life Science
- Founded date
- Jan 1, 2015
- Number Of Employee
- 11 - 50
- Operating Status
- Active
evonetix is a new spin-out company that is currently incubating in the centre of the world-renowned Cambridge cluster of high-tech and life science organisations. We are seeking to develop and commercialise a new approach to the synthesis of DNA to facilitate the fast-emerging and exciting field of synthetic biology. By employing novel techniques we are able to advance DNA synthesis to levels never before seen. Our engineering team has decades of experience developing high integrity automated systems. Our high calibre team brings together expertise from across the scientific and engineering disciplines.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 2, 2020 | Series B | $30M | 1 | — | — | Detail |
| Jan 30, 2018 | Series A | $12.30M | 1 |
Molten Ventures
|
— | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Molten Ventures
|
— | Series B |
